Skip to content

Clinical trials

Schizophrenia Spectrum and Other Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Spectrum and Other Psychotic Disorders Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20063
20081
20095
20102
20111
20121
20133
20144
20154
20164
20176
20184
20197
20204
20215
202210
20236
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status12
Recruiting9
Terminated4
Active, not recruiting2
Not yet recruiting2
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health4
University of Minnesota4
AbbVie3
Fundación Marques de Valdecilla3
Chinese University of Hong Kong2
Karolinska Institutet2
MapLight Therapeutics2
Massachusetts General Hospital2
National Institute on Drug Abuse (NIDA)2
Region Örebro County2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia Spectrum and Other Psychotic Disorders84
Schizophrenia45
Psychotic Disorders40
Mental Disorders23
Bipolar Disorder7
Affective Disorders, Psychotic6
Mood Disorders6
Hallucinations4
Cognitive Dysfunction3
Metabolic Syndrome3

Trials

Showing 76 to 84 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.